Oxidative Medicine and Cellular Longevity / 2021 / Article / Fig 4

Research Article

THAP9-AS1 Promotes Tumorigenesis and Reduces ROS Generation through the JAK2/STAT3 Signaling Pathway by Increasing SOCS3 Promoter Methylation in Osteosarcoma

Figure 4

THAP9-AS1 activated the JAK2/STAT3 signaling pathway by regulating SOCS3. (a) THAP9-AS1 induced p-JAK2 and p-STAT3 (Tyr705) protein upregulation, which could be reversed by SOCS3. (b) p-STAT3 nuclear translocation in the different groups of cells was analyzed by IF assay, and representative images are shown; scale bars: 100 μm. pcSOCS3: SOCS3 expressing vectors.
(a)
(b)

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.